• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Orchid Pharma Limited — Updates, 12-06-2026: General Updates

    12-06-2026 | 12:58 pm

    Orchid Pharma's merger with Dhanuka Labs approved by NCLT, targeting combined sales of Rs. 1400-1500 Cr and EBITDA of Rs. 200-250 Cr. Shareholders receive 161 Orchid shares (FV Rs. 10) for 5 Dhanuka shares (FV Rs. 100). Appointed Date: April 1, 2024.

    No comments yet. Be the first to comment!

    All announcements from Orchid Pharma Limited